openPR Logo
Press release

Investigation announced for Long-Term Investors in NASDAQ: MDXG shares over possible Wrongdoing at MiMedx Group Inc

02-28-2020 04:07 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

An investigation on behalf of investors in MiMedx Group Inc (NASDAQ: MDXG) shares over potential wrongdoing at MiMedx Group Inc.

An investigation on behalf of investors in MiMedx Group Inc (NASDAQ: MDXG) shares over potential wrongdoing at MiMedx Group Inc.

An investigation was announced concerning possible breaches of fiduciary duties by certain directors at MiMedx Group Inc.

Investors who purchased shares of MiMedx Group Inc (NASDAQ: MDXG) and currently hold any of those NASDAQ: MDXG shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain MiMedx Group directors breached their fiduciary duties and caused damage to the company and its shareholders.

On February 24, 2018, a lawsuit was filed against MiMedx Group Inc over alleged violations of Federal Securities Laws. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that MiMedx was engaged in a "channel-stuffing" scheme designed to inappropriately recognize revenue that had not yet been realized, that the Company lacked adequate internal controls over financial reporting, and that that as a result of the foregoing, MiMedx's publicly disseminated financial statements were materially false and misleading

Those who purchased shares of MiMedx Group Inc (NASDAQ: MDXG) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in NASDAQ: MDXG shares over possible Wrongdoing at MiMedx Group Inc here

News-ID: 1949896 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for MiMedx

Amniotic Product Market Massive Growth opportunity Ahead | MiMedx, Smith & Nephe …
Exactitude Consultancy has recently released a comprehensive research report titled "Amniotic Product Market Insights, Extending to 2032." This publication spans over 110+ pages and offers an engaging presentation with visually appealing tables and charts that are self-explanatory. The extensive Amniotic Product market report conducts market research to assist clients in predicting investment in a growing market, expanding their market share, or achieving success with a new product. Various insights about the
Regenerative Medicine Products Market May See a Big Move | Amgen, Medtronic, MiM …
Latest Study on Industrial Growth of Global Regenerative Medicine Products Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Regenerative Medicine Products market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future
Wound Care Biologics Market Growing Massively by Smith and Nephew, Organogenesis …
"Wound Care Biologics Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. The global Wound Care Biologics Market is expected to grow at a significant CAGR of ~5% by 2027. Biologic wound healing therapies are those that are intended to facilitate the re-establishment of
Amniotic Products Market Growth Analysis Report 2022-2028 | MiMedx, Smith & Neph …
Stratagem Market Report published new research on the Global Amniotic Products Market Report covering the micro-level of analysis by competitors and key business segments (2022-2028). The Global Amniotic Products explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the
Regenerative Medicines Market May See Big Move | Stryker, Medtronic, AstraZeneca …
Global Regenerative Medicines Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Regenerative Medicines Market. Some of the key players profiled
Tissue Scaffolds Market Current Trends 2019 | RTI Surgical, Smith & Nephe, MiMed …
A fresh market research study titled Global Tissue Scaffolds Market 2019 explores several significant factors of the market and evaluates the global market. The report includes breakdown data by manufacturers, key regions, types, and application, which presents a detailed analysis of the drivers and restraints impacting the overall global Tissue Scaffolds market. The report simply and plainly presents realistic concepts of the market which are firstly investigated by researchers. The